Aminoglycoside antibiotics traffic to the Golgi complex in LLC-PK1 cells.

Journal of the American Society of Nephrology : JASN
Ruben M SandovalB A Molitoris

Abstract

Aminoglycoside antibiotics are known to be internalized via endocytosis and have been associated with subcellular organelle dysfunction; however, the route of intracellular trafficking and their distribution remain largely unknown. To address these questions, a Texas Red conjugate of gentamicin (TRG) was synthesized for dual-labeling experiments with the endoplasmic reticulum, Golgi, and lysosomal markers DiOC6-3, C6-NBD-ceramide, and fluorescent dextrans, respectively. Confocal images were overlaid to determine areas of colocalization. Initial characterization studies of the fluorescent gentamicin analogue revealed that both internalization and accumulation were inhibited by excess unlabeled gentamicin. Furthermore, the fluorescent gentamicin label was colocalized with unlabeled gentamicin, using immunologic techniques. LLC-PK1 cells were exposed to the fluorescent gentamicin in media containing 1 mg/ml labeled gentamicin for 8 h and then either fixed or chased with gentamicin-free media for an additional 16 or 40 h (24 to 48 h total). Studies with fluorescent dextrans revealed rapid intracellular colocalization within the endosomal and lysosomal systems. Neither endoplasmic reticulum nor mitochondrial colocalization could be ...Continue Reading

Citations

Jan 3, 2001·Journal of the American Society of Nephrology : JASN·David P SundinBruce A Molitoris
Mar 7, 2001·Kidney International·V SorribasM Levi
Jan 25, 2003·Antimicrobial Agents and Chemotherapy·Alexandra S Blackburn, Simon V Avery
Apr 26, 2012·The Annals of Otology, Rhinology, and Laryngology·Jianfen Luo, Lei Xu
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·Hélène ServaisMarie-Paule Mingeot-Leclercq
May 1, 1999·Antimicrobial Agents and Chemotherapy·M P Mingeot-Leclercq, P M Tulkens
Nov 20, 2003·American Journal of Physiology. Renal Physiology·Ruben M Sandoval, Bruce A Molitoris
Apr 23, 2004·American Journal of Physiology. Cell Physiology·Ruben M SandovalBruce A Molitoris
Jul 26, 2005·Toxicology and Applied Pharmacology·Hélène ServaisMarie-Paule Mingeot-Leclercq
Apr 1, 2005·Journal of the American Society of Nephrology : JASN·Donald T WardDaniela Riccardi
Jun 1, 2005·Hearing Research·Sigrid E MyrdalPeter S Steyger
Feb 10, 2006·Hearing Research·C F DaiP S Steyger
Oct 17, 2013·Chemical Research in Toxicology·Maralise Perigolo de OliveiraJean-Luc Décout
Dec 18, 2007·Hearing Research·Chun Fu Dai, Peter S Steyger
Mar 4, 2009·Journal of the Association for Research in Otolaryngology : JARO·Qi Wang, Peter S Steyger
Jun 22, 2010·Hearing Research·Qi WangP S Steyger
Jun 12, 2010·Expert Opinion on Drug Metabolism & Toxicology·Junya Nagai, Mikihisa Takano
May 13, 2011·Nature·Kyle R AllisonJames J Collins

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.